NOVEL RECOMBINANT HIV COMPOSITIONS AND USES THEREOF IN ANIMAL MODELS
- 专利权人:
- Texas Biomedical Research Institute
- 发明人:
- Ruth M. Ruprecht,Samir K. Lakhashe
- 申请号：
- US16348104
- 公开号：
- US20200093916A1
- 申请日:
- 2017.11.07
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided here are certain recombinant HIV compositions and animal models to evaluate prophylactic and therapeutic antiviral compositions.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SYSTÈME D'EXPOSITION POUR AÉROSOL ET INTERACTION DE MATÉRIAU MODÈLE
- Use of inactivated nonreplicating modified vaccinia virus ankara (MVA)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
- use of inactivated non-replicating modified vaccinia ankara virus (mva) as monoimmunotherapy or in combination with solid tumor immune checkpoint blocking agents
- Use of an inactivated non-replicative modified vaccinia virus anchora as a single immunotherapy for solid tumors or in combination with an immuno checkpoint blocking agent
- Recombinant MVA or MVADELE3L expressing human Flt3L and use thereof as immuno-therapeutic agents against solid tumors
